Determinants of health related quality of life and health state utility in patients with age related macular degeneration: The association of contrast sensitivity and visual acuity

Quality of Life Research

Volumn 16, Issue 3, 2007, Pages 533-543

  Bansback, N ^a   Czoski Murray, C ^a   Carlton, J ^c   Lewis, G ^c   Hughes, L ^c   Espallargues, M ^a,b   Brand, C ^c   Brazier, J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Catalan Agency for Health Technology Assessment and Research   (Spain)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Age related macular degeneration; Contrast sensitivity; Health status; Visual acuity

Indexed keywords

ADULT; AGED; ARTICLE; CONTRAST SENSITIVITY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; ECONOMIC EVALUATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; VISION TEST; VISUAL ACUITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTRAST SENSITIVITY; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS; MACULAR DEGENERATION; MALE; MENTAL HEALTH; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VISION TESTS; VISUAL ACUITY;

EID: 33847614833     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-006-9126-8     Document Type: Article

References (26)

1. Meads C, Salas C, Roberts T, Moore D, Fry-Smith A, Hyde C. Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 2003; 7(9): 1-98, v-vi.
2. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing?. Br J Ophthalmol 1996; 80(1): 9-14.
3. Mones J, Rubin GS. Contrast sensitivity as an outcome measure in patients with subfoveal horoidal neovascularisation due to age-related macular degeneration. Eye 2004; 1-9.
4. Rubin GS. Assessment of visual function in eyes with visual loss. Ophthalmol Clin North Am 1989; 2: 357-367.
5. Owsley C, Sekuler R, Boldt C. Aging and low-contrast vision: face perception. Invest Ophthalmol Vis Sci 1981; 21: 362-365.
6. Rubin GS, Bandeen-Roche K, Huang G-H, Munoz B, Schein OD, Fried LP, West SK. The Association of Multiple Visual Impairments with Self-Reported Visual Disability: SEE Project. Invest Ophthalmol Vis Sci 2001; 42: 64-71.
7. Mackenzie PJ, Chang TS, Scott IU, Linder M, Hay D, Feuer WJ, Chambers K. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology 2002; 109(4): 720-729.
8. Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol 2000; 118(1): 47-51.
9. Rubin GS, Bandeen-Roche K, Huang GH, Munoz B, Schein OD, Fried LP, West SK. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci 2001; 42(1): 64-72.
10. Bailey IL, Lovie JE. The design and use of a new near-vision chart. Am J Optom Physiol Opt 1980; 57(6): 378-387.
11. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 1988; 2: 187-199.
12. Williams A. The measurement and valuation of health: A chronicle. Discussion Paper 130. York: Centre for Health Economics, 1995.
13. Dolan P, Gudex C, Kind P, Williams A. Valuing health states: a comparison of methods. J Health Econ 1996; 15(2): 209-231.
14. Cassard SD, Patrick DL, Damiano AM, Legro MW, Tielsch JM, Diener-West M, Schein OD, Javitt JC, Bass EB, Steinberg EP. Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol 1995; 113: 1508-1513.
15. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 2002; 40(2): 113-128.
16. Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, Brand CS, Brazier JE. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci 2005; 46(11): 4016-4023.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences., 2nd ed., New Jersey: Lawrence Erlbaum Associates Inc. Hillsdale, 1988.
18. Rubin GS, Roche KB, Prasada-Rao P, Fried LP. Visual impairment and disability in older adults. Optom Vis Sci 1994; 71: 750-760.
19. Alexander MF, Maguire MG, Lietman TM, Snyder JR, Elman MJ, Fine SL. Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol 1988; 106: 1543-1547.
20. Leat SJ, Woodhouse JM. Reading performance with low vision aids: relationship with contrast sensitivity. Ophthalmic Physiol Opt 1993; 13: 9-16.
21. Legge GE, Ross JA, Isenberg LM, LaMay JM. Psychophysics of reading. Clinical predictors of low-vision reading speed. Invest Ophthalmol Vis Sci 1992; 33: 677-687.
22. Tejeria L, Harper RA, Artes PH, Dickinson CM. Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device. Br J Ophthalmol 2002; 86: 1019-1026.
23. McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?. Br J Ophthalmol 2000; 84(3): 244-250.
24. Dolan P, Roberts J. To what extent can we explain time trade-off values from other information about respondents?. Soc Sci Med 2002; 54(6): 919-929.
25. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119(7): 1050-1058.
26. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2002; 108: 2051-2059.